Want to know more

Cambridge Consultants' Harshal Shah, head of oncology innovations for global medical technology presents on how miniature active implants are a key area for innovation in next-generation drug delivery.

Innovation in drug delivery devices has evolved at a constant pace for 30 years, improving outcomes with better delivery of lifesaving drugs. Now, we’re entering a new era – as we look forward to a decade of innovation and commercial opportunity in active implants.

Watch this presentation to learn more. 

Related Content

Harshal Shah
Head of Oncology Innovations, Global Medical Technology

Harshal is part of our global medical division based out of Boston, with more than a decade of experience in medical device development, product life cycle strategy, and innovation management. He has significant expertise in oncology patient journey, economics of cancer care and innovations in oncology. He has a Bachelor of Mechanical Engineering degree from Nirma Institute of Technology in India, an MBA from Syracuse University, New York, and he recently completed a post graduate program in cancer biology and therapeutics development from Harvard Medical School.